Abstract:LI-F type peptides (AMP-jsa9) produced by Paenibacillus polymyxa JSa-9 are a group of cyclic lipodepsipeptide antibiotics that exhibit a broad antimicrobial spectrum against Gram-positive bacteria and filamentous fungi, especially Bacillus cereus and Fusarium moniliforme. In this study, to better understand the antibacterial mechanism of AMP-jsa9 against B. cereus, the ultrastructure of AMP-jsa9-treated B. cereus cells was observed by both atomic force microscopy and transmission electron microscopy, and quantitative proteomic analysis was performed on proteins extracted from treated and untreated bacterial cells by using isobaric tag for relative and absolute quantitation (iTRAQ) labeling and LC-MS/MS analysis to access differentially expressed proteins. Furthermore, multiple experiments were conducted to validate the results of the proteomic analysis, including determinations of ATP, NAD(+)H, NADP(+)H, reactive oxygen species (ROS), the activities of catalase (CAT) and superoxide dismutase (SOD), and the relative expression of target genes by quantitative real-time PCR. Bacterial cells exposed to AMP-jsa9 showed irregular surfaces with bleb projections and concaves; we hypothesize that AMP-jsa9 penetrated the cell wall and was anchored on the cytoplasmic membrane and that ROS accumulated in the cell membrane after treatment with AMP-jsa9, modulating the bacterial membrane properties and increasing membrane permeability. Consequently, the blebs were formed on the cell wall by the impulsive force of the leakage of intercellular contents. iTRAQ-based proteomic analysis detected a total of 1317 proteins, including 176 differentially expressed proteins (75 upregulated (fold >2) and 101 downregulated (fold <0.5)). Based on proteome analysis, the putative pathways of AMP-jsa9 action against B. cereus can be summarized as: (i) inhibition of bacterial sporulation, thiamine biosynthesis, energy metabolism, DNA transcription and translation, and cell wall biosynthesis, through direct regulation of protein levels; and (ii) indirect effects on the same pathways through the accumulation of ROS and the consequent impairment of cellular functions, resulting from downregulation of antioxidant proteins, especially CAT and SOD. Biological significance: The mode of action of LI-F type antimicrobial peptides (AMP-jsa9) against B. cereus was elucidated at the proteomic level. Two pathways of AMP-jsa9 action upon B. cereus cells were identified and the mechanism of bleb formation on the surfaces of bacterial cells was predicted based on the results of ultrastructural observation and proteomic analysis. These results are helpful in understanding the mechanism of LI-F type peptides and in providing the theoretical base for applying AMP-jsa9 or its analogs to combat Gram-positive pathogenic bacteria in the food and feed industries.

Bacteriostatic Effect of Lipopeptides from Bacillus Subtilis N-2 on Pseudomonas Putida Using Soybean Meal by Solid-State Fermentation

Study on the Anti-Aeromonas Hydrophila Effect in Vitro of Lipopeptide from Bacillus Subtilis Fmbj

Isolation and Identification of Antibacterial Lpopeptides from Bacillus Subtilis KC-WQ Fermentation Broth and Optimization of Fermentation Conditions

Identification and Characterization of Antibacterial Metabolites and Optimization of Cultural Conditions for Bacillus subtilis

Optimization of Fermentation Medium for Production of Antibacterial Peptides by Bacillus Subtilis BSD-2

Screening of Antagonistic Bacteria against Three Aquatic Pathogens and Characterization of Lipopeptides in Bacillus cereus BA09

Antimicrobial Activity of Liner Lipopeptides Produced by Bacillus Subtilis HS-A38

Bacillus subtilis TR47II as a source of bioactive lipopeptides against Gram-negative pathogens causing nosocomial infections

Co-producing Lipopeptides and Poly-Γ-glutamic Acid by Solid-State Fermentation of Bacillus Subtilis Using Soybean and Sweet Potato Residues and Its Biocontrol and Fertilizer Synergistic Effects

The Application of Bacillus Subtilis for Adhesion Inhibition of Pseudomonas and Preservation of Fresh Fish

A marine lipopeptides-producing Bacillus amyloliquefaciens HY2-1 with a broad-spectrum antifungal and antibacterial activity and its fermentation kinetics study

Isolation, Purification and Solubility of Antibacterial Substances from Fermentation Supernatant of Marine Streptomyces Parvus DY2741

Isolation of a novel Bacillus subtilis HF1 strain that is rich in lipopeptide homologs and has strong effects on the resistance of plant fungi and growth improvement of broilers

Co-production of surfactin and fengycin by Bacillus subtilis BBW1542 isolated from marine sediment: a promising biocontrol agent against foodborne pathogens

Isolation and Characterization of Antifungal Lipopeptides Produced by Endophytic Bacillus Amyloliquefaciens Tf28

The Ability of Marine Bacillus Spp. Isolated from Fish Gastrointestinal Tract and Culture Pond Sediment to Inhibit Growth of Aquatic Pathogenic Bacteria

Isolation and identification of protease-producing Bacillus amyloliquefaciens LX-6 and its application in the solid fermentation of soybean meal

Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

iTRAQ-based proteomic analysis of LI-F type peptides produced by Paenibacillus polymyxa JSa-9 mode of action against Bacillus cereus

Production of lipopeptides by Bacillus subtilis in solid status fermentation and their application in antifungal and heavy metal remove

A novel thermophilic strain of Bacillus subtilis with antimicrobial activity and its potential application in solid-state fermentation of soybean meal